The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Abstract

AbstractBackground and AimGlobally, pancreatic cancer is recognized as one of the most lethal types of cancers. We report the burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa (MENA) region, from 1990 to 2019, by age, sex, and socio‐demographic index.MethodsPublicly available data from the Global Burden of Disease 2019 study were used to report the incidence, deaths, and disability‐adjusted life years (DALYs) attributable to pancreatic cancer, as counts and age‐standardized rates with 95% uncertainty intervals.ResultsIn 2019, pancreatic cancer had an age‐standardized incidence rate of 5.3 and a death rate of 5.5 (per 100 000) in MENA, which have increased by 97.5% and 93.4%, respectively, since 1990. There were 563.6 thousand DALYs attributable to pancreatic cancer in 2019, with an age‐standardized DALY rate of 123.0, which has increased by 84.9% since 1990. The highest number of incident cases was found in the 60–64 and 65–69 age groups, among male and female, respectively. In addition, the MENA/global DALY ratios were higher in all age groups for both sexes in 2019, than they were in 1990. There was a positive association between socio‐demographic index and the burden of pancreatic cancer. Smoking, high fasting plasma glucose, and high body mass index were responsible for 19.2%, 9.3%, and 9.3% of the attributable DALYs in 2019, respectively.ConclusionsThere was a clear and substantial increase in the burden of pancreatic cancer in the MENA region. Prevention programs should be implemented in the region that target these three risk factors.